IllustrativeHHS floats new DTC guidance so pharma won't run afoul of anti-kickback laws
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
The department of health and human services is considering new guidance for direct-to-consumer pharmaceutical activities. This guidance is intended to help pharmaceutical companies avoid violating anti-kickback laws. The proposed guidance may affect how pharmaceutical companies interact with consumers.